Published: Guidance, quality standards and advice
Showing 1 to 3 of 3
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal) | TA826 | ||
| Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy | TA352 | ||
| Vedolizumab for treating moderately to severely active ulcerative colitis | TA342 |